Minerva Neurosciences | Eigenkapital Und Reserven

Equity Capital And Reserves Veränderung Datum
Acadia Pharmaceuticals USD 431.76M 69.58M 2023-12
Adma Biologics USD 135.21M 16.23M 2023-12
ALKERMES USD 1.36B 75.15M 2023-09
AstraZeneca USD 37.2B 195M 2023-09
Bristol-Myers Squibb USD 29B 2.98B 2023-09
Clal Biotechnology ILS 126.03M 5.92M 2022-12
Compugen USD 53.23M 8.77M 2023-09
CSL USD 15.79B 110.2M 2023-06
Dynavax Technologies USD 622.07M 17.16M 2023-12
Eli Lilly USD 11.22B 156.6M 2023-09
GlaxoSmithKline GBP 13.13B 442M 2023-09
Grifols EUR 6.13B 265.26M 2023-09
Halozyme Therapeutics USD 83.81M 165.37M 2023-12
Ionis Pharmaceuticals USD 386.69M 71.23M 2023-12
Merck USD 41.25B 2.55B 2023-09
Neurocrine Biosciences USD 2B 149.1M 2023-09
Pfizer USD 96.93B 2.08B 2023-09
Roche Holding CHF 26.52B 1.48B 2023-06
Takeda JPY 7.07T 149.3B 2023-09



Minerva Neurosciences Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2024.